Literature DB >> 20697097

Circulating miRNA signatures: promising prognostic tools for cancer.

Helen M Heneghan, Nicola Miller, Michael J Kerin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20697097     DOI： 10.1200/JCO.2010.29.8901

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  27 in total

Review 1.  Translational application of epigenetic alterations: ovarian cancer as a model.

Authors:  Marie E Maradeo; Paul Cairns
Journal:  FEBS Lett       Date:  2011-03-12       Impact factor: 4.124

Review 2.  Peripheral blood microRNAs: A novel tool for diagnosing disease?

Authors:  Ziqiang Wang; Yanqin Lu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2012-08

3.  The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.

Authors:  Nancy S Vetter; E A Kolb; Christopher C Mills; Valerie B Sampson
Journal:  Mol Cancer Res       Date:  2017-03-08       Impact factor: 5.852

4.  Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.

Authors:  Colin C Pritchard; Evan Kroh; Brent Wood; Jason D Arroyo; Katy J Dougherty; Melanie M Miyaji; Jonathan F Tait; Muneesh Tewari
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-12

Review 5.  MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential.

Authors:  Wei Wang; Yun-ping Luo
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066

Review 6.  A review of prognostic and predictive biomarkers in breast cancer.

Authors:  Elaheh Tarighati; Hadi Keivan; Hojjat Mahani
Journal:  Clin Exp Med       Date:  2022-01-15       Impact factor: 3.984

7.  Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis.

Authors:  Yongchun Shen; Tao Wang; Ting Yang; Qianjing Hu; Chun Wan; Lei Chen; Fuqiang Wen
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-06

Review 8.  New insights into p53 functions through its target microRNAs.

Authors:  Jun-Ming Liao; Bo Cao; Xiang Zhou; Hua Lu
Journal:  J Mol Cell Biol       Date:  2014-04-15       Impact factor: 6.216

Review 9.  Circulating microRNAs as biomarkers for inflammatory diseases.

Authors:  Shuangli Mi; Jian Zhang; Wei Zhang; R Stephanie Huang
Journal:  Microrna       Date:  2013

10.  miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.

Authors:  Zhigang Wang; Meng Wei; Yi Ren; Hua Liu; Meng Wang; Kehui Shi; Hongli Jiang
Journal:  Tumour Biol       Date:  2014-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.